Cited by

• Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia.

  Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, Li L, Yuan H, Shi L, Zhang C, Gao Y, Liu S, Xu H, Liu H, Liang S, Li G. Jia T, et al. Front Neurosci. 2018 Jan 25;11:755. doi: 10.3389/fnins.2017.00755. eCollection 2017. Front Neurosci. 2018. PMID: 29422835 Free PMC article.
• Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy.

  Yoo M, Sharma N, Pasnoor M, Kluding PM. Yoo M, et al. J Diabetes Metab. 2013 Jun 30;Suppl 10:005. doi: 10.4172/2155-6156.S10-005. J Diabetes Metab. 2013. PMID: 25360348 Free PMC article.
• Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy.

  Yoo M, D'Silva LJ, Martin K, Sharma NK, Pasnoor M, LeMaster JW, Kluding PM. Yoo M, et al. Pain Med. 2015 Aug;16(8):1482-9. doi: 10.1111/pme.12743. Epub 2015 Mar 20. Pain Med. 2015. PMID: 25800666 Free PMC article.
• PIAS1 alleviates diabetic peripheral neuropathy through SUMOlation of PPAR-γ and miR-124-induced downregulation of EZH2/STAT3.

  Hou Z, Chen J, Yang H, Hu X, Yang F. Hou Z, et al. Cell Death Discov. 2021 Dec 2;7(1):372. doi: 10.1038/s41420-021-00765-w. Cell Death Discov. 2021. PMID: 34857740 Free PMC article.
• Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

  Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL; Alliance for Clinical Trials in Oncology. Smith EM, et al. JAMA. 2013 Apr 3;309(13):1359-67. doi: 10.1001/jama.2013.2813. JAMA. 2013. PMID: 23549581 Free PMC article. Clinical Trial.